Table 3. Risk factors for outcome .... | American Society of Hematology

Table 3.

Risk factors for outcome

	Overall survival			Leukemia-free survival
	Univariate	Multivariate (HR)	Univariate	Multivariate (HR)
Stage at SCT, PIF vs other	.017	NS	.006	NS
No. of chemotherapy cycles before SCT, 2 vs more than 2	.008	.007 (3.01)	.008	.002 (3.25)
BM infiltration by leukemic blasts at SCT, less than or greater than 50%	.07	NS	.09	NS
Time from diagnosis to SCT, less than or greater than median	.011	NS	.008	NS
CD34⁺ cell counts in the graft, less than or greater than median	.028	.047 (2.00)	.02	.05 (1.8)

	Overall survival			Leukemia-free survival
	Univariate	Multivariate (HR)	Univariate	Multivariate (HR)
Stage at SCT, PIF vs other	.017	NS	.006	NS
No. of chemotherapy cycles before SCT, 2 vs more than 2	.008	.007 (3.01)	.008	.002 (3.25)
BM infiltration by leukemic blasts at SCT, less than or greater than 50%	.07	NS	.09	NS
Time from diagnosis to SCT, less than or greater than median	.011	NS	.008	NS
CD34⁺ cell counts in the graft, less than or greater than median	.028	.047 (2.00)	.02	.05 (1.8)

HR indicates hazard ratio; NS, not significant.